CBUS Cibus Global LLC

USD 9.94 0.00 0
Icon

Cibus Global LLC (CBUS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 9.94

0.00 (0.00)%

USD 0.26B

0.18M

USD 25.00(+151.51%)

N/A

Icon

CBUS

Cibus Global LLC (USD)
COMMON STOCK | NSD
USD 9.94
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.26B

N/A

USD 9.94

Cibus Global LLC (CBUS) Stock Forecast

Show ratings and price targets of :
USD 25.00
(+151.51%)

Based on the Cibus Global LLC stock forecast from 1 analysts, the average analyst target price for Cibus Global LLC is USD 25.00 over the next 12 months. Cibus Global LLC’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cibus Global LLC is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Cibus Global LLC’s stock price was USD 9.94. Cibus Global LLC’s stock price has changed by +23.02% over the past week, -0.90% over the past month and -53.81% over the last year.

No recent analyst target price found for Cibus Global LLC
No recent average analyst rating found for Cibus Global LLC

Company Overview Cibus Global LLC

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the...Read More

https://www.cibus.com

6455 Nancy Ridge Drive, San Diego, CA, United States, 92121

183

December

USD

United States

Adjusted Closing Price for Cibus Global LLC (CBUS)

Loading...

Unadjusted Closing Price for Cibus Global LLC (CBUS)

Loading...

Share Trading Volume for Cibus Global LLC Shares

Loading...

Compare Performance of Cibus Global LLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CBUS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Cibus Global LLC (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing CBUS

Symbol Name CBUS's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Cibus Global LLC (CBUS) Stock

Based on ratings from 1 analysts Cibus Global LLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on CBUS's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for CBUS is USD 25.00 over the next 12 months. The maximum analyst target price is USD 25 while the minimum anlayst target price is USD 25.

Unfortunately we do not have enough data on CBUS's stock to indicate if its overvalued.

The last closing price of CBUS's stock was USD 9.94.

The most recent market capitalization for CBUS is USD 0.26B.

Based on targets from 1 analysts, the average taret price for CBUS is projected at USD 25.00 over the next 12 months. This means that CBUS's stock price may go up by +151.51% over the next 12 months.

We can't find any ETFs which contains Cibus Global LLC's stock.

As per our most recent records Cibus Global LLC has 183 Employees.

Cibus Global LLC's registered address is 6455 Nancy Ridge Drive, San Diego, CA, United States, 92121. You can get more information about it from Cibus Global LLC's website at https://www.cibus.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...